Our finding that MYC expression is closely related to the expression of oncogenic genes, including those in the Ras, mTOR, and CCND signaling pathways, provides new insights that may aid in the development of novel molecular‐targeted drugs for the treatment of patients with DLBCL. Here, MTOR is linked to diffuse large B-cell lymphoma.